On November 9, 2022 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, reported that members of the RAPT management team will participate in the following investor conferences in November (Press release, RAPT Therapeutics, NOV 9, 2022, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-participate-several-upcoming-investor-0 [SID1234623528]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 4th Annual Immunology and Neurology Day – Tuesday, November 15, 2022, at 2:10 p.m. ET in New York, NY
Piper Sandler 33rd Annual Healthcare Conference – Tuesday, November 29, 2022, at 8:00 a.m. ET in New York, NY
Evercore ISI 5th Annual Virtual HealthCONx Conference – Wednesday, November 30, 2022, at 3:55 p.m. ET
To access the live webcasts or subsequent archived recordings of the company presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.